Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between circulating tumor cells, blood coagulation, and urokinase-plasminogen-activator system in early breast cancer patients.
Mego M, Karaba M, Minarik G, Benca J, Sedlácková T, Tothova L, Vlkova B, Cierna Z, Janega P, Luha J, Gronesova P, Pindak D, Fridrichova I, Celec P, Reuben JM, Cristofanilli M, Mardiak J. Mego M, et al. Among authors: fridrichova i. Breast J. 2015 Mar-Apr;21(2):155-60. doi: 10.1111/tbj.12388. Epub 2015 Jan 27. Breast J. 2015. PMID: 25623304
CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers.
Fridrichova I, Smolkova B, Kajabova V, Zmetakova I, Krivulcik T, Mego M, Cierna Z, Karaba M, Benca J, Pindak D, Bohac M, Repiska V, Danihel L. Fridrichova I, et al. Transl Res. 2015 Jun;165(6):717-30. doi: 10.1016/j.trsl.2014.12.006. Epub 2015 Jan 9. Transl Res. 2015. PMID: 25620615
Expression of SOCS1 and CXCL12 Proteins in Primary Breast Cancer Are Associated with Presence of Circulating Tumor Cells in Peripheral Blood.
Smolkova B, Mego M, Horvathova Kajabova V, Cierna Z, Danihel L, Sedlackova T, Minarik G, Zmetakova I, Krivulcik T, Gronesova P, Karaba M, Benca J, Pindak D, Mardiak J, Reuben JM, Fridrichova I. Smolkova B, et al. Among authors: fridrichova i. Transl Oncol. 2016 Jun;9(3):184-90. doi: 10.1016/j.tranon.2016.03.004. Epub 2016 Apr 25. Transl Oncol. 2016. PMID: 27267835 Free PMC article.
Down-regulation of traditional oncomiRs in plasma of breast cancer patients.
Jurkovicova D, Smolkova B, Magyerkova M, Sestakova Z, Kajabova VH, Kulcsar L, Zmetakova I, Kalinkova L, Krivulcik T, Karaba M, Benca J, Sedlackova T, Minarik G, Cierna Z, Danihel L, Mego M, Chovanec M, Fridrichova I. Jurkovicova D, et al. Among authors: fridrichova i. Oncotarget. 2017 Aug 24;8(44):77369-77384. doi: 10.18632/oncotarget.20484. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100393 Free PMC article.
A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.
Zmetakova I, Kalinkova L, Smolkova B, Horvathova Kajabova V, Cierna Z, Danihel L, Bohac M, Sedlackova T, Minarik G, Karaba M, Benca J, Cihova M, Buocikova V, Miklikova S, Mego M, Fridrichova I. Zmetakova I, et al. Among authors: fridrichova i. Cancer Sci. 2019 May;110(5):1695-1704. doi: 10.1111/cas.13985. Epub 2019 Mar 18. Cancer Sci. 2019. PMID: 30815959 Free PMC article.
RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
Sebova K, Zmetakova I, Bella V, Kajo K, Stankovicova I, Kajabova V, Krivulcik T, Lasabova Z, Tomka M, Galbavy S, Fridrichova I. Sebova K, et al. Among authors: fridrichova i. Cancer Biomark. 2011-2012;10(1):13-26. doi: 10.3233/CBM-2012-0230. Cancer Biomark. 2011. PMID: 22297548
34 results